Table 3.
Gut leakage markers at baseline in all patients and according to coronary artery disease.
| All (n = 287) | No CAD (n = 69) | Non-Significant CAD (n = 88) | Significant CAD (n = 130) | p-Value 1 | p-Value 2 | p-Value 3 | |
|---|---|---|---|---|---|---|---|
| sCD14 (ng/mL) | 1353 (1217, 1560) | 1419 (1224, 1600) | 1402 (1220, 1607) | 1329 (1194, 1495) | 0.097 | 0.312 | 0.107 |
| LBP (ng/mL) | 15,805 (13,378, 19,045) | 15,033 (12,276, 18,593) | 15,562 (12,723, 19,032) | 16,293 (13,877, 19,233) | 0.415 | 0.318 | 0.232 |
| I-FABP (pg/mL) | 927 (631, 1324) | 943 (677, 1287) | 894 (600, 1341) | 925 (629, 1292) | 0.811 | 0.832 | 0.981 |
| All (n = 101) | No CAD (n = 29) | Non-Significant CAD (n = 27) | Significant CAD (n = 45) | ||||
| LPS (pg/mL) | 77.1 (64.0, 90.2) | 74.3 (60.9, 89.2) | 78.5 (66.3, 94.0) | 78.3 (67.9, 91.2) | 0.661 | 0.372 | 0.441 |
| TLR4 receptor (RQ) | 1.1 (0.9, 1.6) | 1.3 (0.9, 1.7) | 1.1 (0.8, 1.6) | 1.1 (0.9, 1.4) | 0.403 | 0.180 | 0.199 |
1 refers to difference between groups of CAD. 2 Refers to differences between no CAD and any CAD (non-significant CAD and significant CAD together). 3 refers to differences between no CAD and significant CAD. All variables are presented as medians (25th, 75th percentiles).